Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.
Loading...
Embargo End Date
ICR Authors
Authors
Browning, L
Colling, R
Rakha, E
Rajpoot, N
Rittscher, J
James, JA
Salto-Tellez, M
Snead, DRJ
Verrill, C
Colling, R
Rakha, E
Rajpoot, N
Rittscher, J
James, JA
Salto-Tellez, M
Snead, DRJ
Verrill, C
Document Type
Journal Article
Date
2020-07-03
Date Accepted
2020-06-15
Abstract
The measures to control the COVID-19 outbreak will likely remain a feature of our working lives until a suitable vaccine or treatment is found. The pandemic has had a substantial impact on clinical services, including cancer pathways. Pathologists are working remotely in many circumstances to protect themselves, colleagues, family members and the delivery of clinical services. The effects of COVID-19 on research and clinical trials have also been significant with changes to protocols, suspensions of studies and redeployment of resources to COVID-19. In this article, we explore the specific impact of COVID-19 on clinical and academic pathology and explore how digital pathology and artificial intelligence can play a key role to safeguarding clinical services and pathology-based research in the current climate and in the future.
Citation
Journal of clinical pathology, 2020
Source Title
Publisher
BMJ PUBLISHING GROUP
ISSN
0021-9746
eISSN
1472-4146
Collections
Research Team
Integrated Pathology